Videos and Recordings

Videos and Recordings

June 24, 2019
Ultra-Sensitive Biomarker Measurement in Neurology Research using Simoa Technology. Utilization of Blood Biomarkers in Neurodegenerative Disease Research Biomarker World Congress and IO Pharma Congress, World Pharma Week, June 2019
June 24, 2019
The ultra-sensitive measurement of proteins as biomarkers of Immuno-Oncology therapeutics using Simoa platforms.  Biomarker World Congress and IO Pharma Congress, World Pharma Week, June 2019
June 24, 2019
Delivering ultrasensitive biomarker measurement you can count on.
June 10, 2019
CEO Kevin Hrusovsky took the stage in front of an enthusiastic audience this week at the BIO International Convention to share how Quanterix Simoa® ultra-sensitive biomarker technology platforms are disrupting healthcare and propelling drug discovery forward.
Bloomberg Radio Interview | February 07, 2019
In a conversation with Tom Moroney and Peter Barnes that highlights the power of the protein, Quanterix CEO Kevin Hrusovsky explains how Simoa is powering advances in research, specifically for the detection and treatment of Alzheimer’s and other neurodegenerative diseases.  
WCVB News Boston | February 06, 2019
WCVB's Emily Reimer explores Quanterix' next generation Simoa planar array technology.